The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.
Open accessAbstract
Central to the pathogenesis of osteoporosis is the ability of estrogen deficiency to increase osteoclast formation by enhancing stromal cell production of the osteoclastogenic cytokine macrophage colony-stimulating factor (M-CSF). We report that stromal cells from ovariectomized mice exhibit increased casein kinase II-dependent phosphorylation of the nuclear protein Egr-1. Phosphorylated Egr-1 binds less avidly to the transcriptional activator Sp-1 and the resulting higher levels of free Sp-1 stimulate transactivation of the M-CSF gene. Estrogen replacement fails to block M-CSF mRNA expression and osteoclast formation in ovariectomized mice lacking Egr-1, confirming the critical role played by this transcription factor in mediating the antiosteoclastogenic effects of estrogen. Thus, by downregulating formation of a novel Egr-1/Sp-1 complex in stromal cells, estrogen deficiency results in enhanced levels of free Sp-1 and increased M-CSF gene expression and osteoclast formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273 · cited 1×
“Furthermore, since M-CSF is critical for murine osteoclastogenesis (3, 4), and the functional block of IL-1 and TNF with IL-1ra and TNFbp also prevents the ovx-induced bone loss (47, 48) and increase in OC formation (17), the data also explain how IL-1 and TNF mediate the postmenopausal increase in bone resorption.”
BackgroundSelf-citation
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Self-citationChanges in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705
“Contributing to the enhanced osteoclastogenesis of estrogen deficiency are increased production of MCSF (16, 20) and blunted release of the RANKL decoy receptor osteoprotegerin (OPG) (21) from bone mar- row stromal cells.”
BackgroundResultInfluentialSelf-citationOsteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
Manolagas, S. C. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.385 · Cited by 517
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Self-citationHavis, E., & Duprez, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051664 · Cited by 494
Srivastava, S., Toraldo, G., Weitzmann, M. N., Cenci, S., Ross, F. P., & Pacifici, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010764200 · Cited by 358
Self-citationαvβ3and macrophage colony‐stimulating factor: partners in osteoclast biology
Ross, F. P., & Teitelbaum, S. L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00331.x · Cited by 303
Self-citationMolecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R. C., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 299
M-CSF mediates TNF-induced inflammatory osteolysis
Kitaura, H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26132 · Cited by 292
Early Growth Response-1 in Cardiovascular Pathobiology
Khachigian, L. M. (2006) · Circulation Research · doi:10.1161/01.res.0000200177.53882.c3 · Cited by 277
Weitzmann, M. N., Cenci, S., Rifas, L., Brown, C., & Pacifici, R. (2000) · Blood · doi:10.1182/blood.v96.5.1873 · Cited by 265
Self-citationEstrogen Receptor Signaling in the Immune System
Chakraborty, B., Byemerwa, J., Krebs, T., Lim, F., Chang, C.-Y., & McDonnell, D. P. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac017 · Cited by 263
Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S., & Pacifici, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7094 · Cited by 255
Self-citationBlaber, E. A., Dvorochkin, N., Lee, C., Alwood, J. S., Yousuf, R., Pianetta, P., Globus, R. K., Burns, B. P., & Almeida, E. A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061372 · Cited by 196
“Furthermore, decreased levels of Egr1 leads to decreased formation of the Egr1/Sp1 complex resulting in increased levels of free Sp1 available for binding to the m-CSF promoter, increased m-CSF expression, and consequently, more osteoclast formation [69].”
BackgroundSaika, M., Inoue, D., Kido, S., & Matsumoto, T. (2001) · Endocrinology · doi:10.1210/endo.142.6.8220 · Cited by 194
Regulation of the neuronal proteasome by Zif268 (Egr1)
James, A. B., Conway, A.-M., & Morris, B. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4199-05.2006 · Cited by 94
Ayturk, U. M., Jacobsen, C. M., Christodoulou, D. C., Gorham, J., Seidman, J. G., Seidman, C. E., Robling, A. G., & Warman, M. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1946 · Cited by 84
“For example, transcripts for osteoinductive factors, such as Egr1,(31,32) Il‐6,(33) and Cxcl2(34) were 522‐fold, 6277‐fold, and 11,799‐fold more abundant, respectively, and components of the transcription factor Ap‐1 complex,(35,36) such as Fos, Fosb, Jun, and Atf3, were 82,070‐fold, 4394‐fold, 96‐fold, and 1775‐fold…”
BackgroundDalcq, J., Pasque, V., Ghaye, A., Larbuisson, A., Motte, P., Martial, J. A., & Muller, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050140 · Cited by 52
“Egr1 KO mice present increased bone resorption, a reduced bone mass and an increased production of the osteoclastogenic cytokine M-CSF (macrophage Colony-Stimulating Factor) in stromal cells of the bone matrix [38,39,40].”
BackgroundO’Shea, P. J., Guigon, C. J., Williams, G. R., & Cheng, S.-Y. (2007) · Endocrinology · doi:10.1210/en.2007-0114 · Cited by 22
Metadata
- Authors
- Srivastava, S., Weitzmann, M. N., Kimble, R. B., Rizzo, M., Zahner, M., Milbrandt, J., Ross, F. P., & Pacifici, R.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-11-15
- Volume
- 102
- Issue
- 10
- Pages
- 1850-1859
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2067754245
- Cited by
- 202
- References
- 2
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.